For an alternative, take a look at Optery (YC W22). We've been flagging the situation at OneRep for years and put a statement out following the Krebs article (link below). We launched to the public as a Show HN in 2021 and as a Launch HN in 2022. Full disclosure, I'm one of the Optery founders.
https://www.optery.com/optery-statement-following-investigat...